- Ramucirumab(), sold
under the
brand name
Cyramza, is a
fully human monoclonal antibody (IgG1) used for the
treatment of cancer.
Ramucirumab is a human...
- 2020-02-21. "FDA
approves Cyramza for
stomach cancer". FDA NEWS RELEASE. U.S. Food and Drug Administration. "Lilly's
CYRAMZA™ (ramucirumab)
Becomes First...
-
cyprodenate (INN)
cyproheptadine (INN)
cyprolidol (INN)
cyproterone (INN)
Cyramza cyromazine (INN)
Cystadane Cystadrops Cystagon Cystaran cysteamine bitartrate...
-
Lilly include Trulicity, Mounjaro, Verzenio, Taltz, Jardiance, Humalog,
Cyramza, Olumiant, Emgality, Tyvyt, Retevmo, Alimta, and Zepbound. In 2003, Eli...
-
Lucinactant (Surfaxin) for
infant respiratory distress syndrome Ramucirumab (
Cyramza) for
gastric and non-small cell lung
cancer Dinutuximab (Unituxin) for...
- (prophylaxis)
Ralpancizumab mab
humanized PCSK9
dyslipidemia Ramucirumab Cyramza mab
human VEGFR2 Y
solid tumors Ranevetmab mab
veterinary NGF osteoarthritis...
-
intravenous humanized HER2
Metastatic breast cancer 125409 Link
ramucirumab Cyramza Eli
Lilly 4/21/2014
intravenous fully human VEGFR2
Gastric cancer 125477...
- 1016/j.tips.2021.07.004. hdl:10044/1/102175. PMID 34446297.
Ramucirumab (
Cyramza)
package insert Ruch JM,
Hussain MH (15 May 2011). "Evolving Therapeutic...
